UPDATE 1-Roche rheumatoid arthritis drug fails to help COVID-19 patients in Italian study
Roche's rheumatoid arthritis drug Actemra failed to help patients with early-stage COVID-19 pneumonia in an Italian study, researchers reported on Wednesday, but the Swiss drugmaker is testing the medicine in another trial against the illness caused by the new coronavirus. [Source]
Publication Date:Origin: reuters.com
Category: companyNews
Topics: study, Italian, patients, rheumatoid, coronavirus, caused, illness, against, trial, in another, medicine, testing, drugmaker, Swiss, on Wednesday, reported, researchers, COVID-19 pneumonia, early-stage, failed, Actemra, arthritis drug, Roche's, COVID-19, fails, arthritis, 1-Roche, UPDATE